- K3326X and Other C-Terminal BRCA2 Variants Implicated in Hereditary Cancer Syndromes: A Review.
- Baughan S, Tainsky MA.
- Cancers (Basel). 2021 Jan 25;13(3):E447. doi: 10.3390/cancers13030447.
- Review
- Free Full Text
- Economic impact of multigene panel testing for hereditary breast and ovarian cancer.
- Byfield SD, Wei H, DuCharme M, Lancaster JM.
- J Comp Eff Res. 2021 Jan 25. doi: 10.2217/cer-2020-0192. Epub ahead of print.
- PMID: 33491479
- PubMed abstract
- Source abstract